Company news

EXACT Therapeutics AS news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

EXACT Therapeutics publishes shareholder information regarding the delisting

September 4, 2026

EXACT Therapeutics AS - Issuance of share options

August 31, 2026

EXACT Therapeutics AS: Oslo Stock Exchange approves application to delist EXACT Therapeutics’ shares

July 2, 2026

EXACT Therapeutics AS - Removal from trading

June 30, 2026

EXACT Therapeutics: Announces webcast regarding strategic intent to delist the company's shares from listing on Euronext Growth, Oslo

June 1, 2026

EXACT Therapeutics: Strategic intent to delist the company's shares from listing on Euronext Growth, Oslo

May 29, 2026

EXACT Therapeutics AS: Share capital increase registered

March 26, 2026

Notice of Extraordinary General Meeting for EXACT Therapeutics March 13, 2026

March 13, 2026

First patient dosed in Europe in Phase 2 trial in patients with locally advanced pancreatic cancer

March 3, 2026

EXACT Therapeutics AS: Notice of extraordinary general meeting

February 27, 2026

EXACT Therapeutics AS: Warrants exercise

February 27, 2026

EXACT Therapeutics: Investor presentation for the global investor call regarding the ongoing warrants exercise program

February 11, 2026

EXACT Therapeutics: Global investor call regarding the ongoing warrants exercise program

February 6, 2026

EXACT Therapeutics: Exercise of Warrants by GE Medical Holding AB

February 5, 2026

EXACT Therapeutics: Positive initial safety read-out from the Phase 2 ENACT trial in pancreatic cancer, triggering option to exercise warrants

January 27, 2026

Positive initial safety read-out from the Phase 2 ENACT trial in pancreatic cancer, triggering option to exercise warrants

January 27, 2026

EXACT Therapeutics AS: New option program and receipt of share options by primary insiders

November 24, 2025

EXACT Therapeutics first half 2025 interim results

September 25, 2025

EXACT Therapeutics announces grant of core patent in the U.S.

September 15, 2025

EXACT Therapeutics announces first patient dosed in Phase 2 trial in patients with locally advanced pancreatic cancer

June 24, 2025

EXACT Therapeutics announces positive final results in Phase 1 ACTIVATE trial in liver metastases from colorectal cancer

May 20, 2025

Decks

The 5 newest of 6 decks. Every deck is listed under its year.